Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor de Ledinghen

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Journal of Hepatology|June 6, 2016
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT studyAudrey Coilly, Claire Fougerou-Leurent, Victor de Ledinghen, et al.
Hepatology (Baltimore, Md.)|April 11, 2018
12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver TransplantationPauline Houssel-Debry, Audrey Coilly, Claire Fougerou-Leurent, et al.
Journal of Hepatology|April 11, 2019
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the differenceLina Mouna, Emilie Rossignol, Mariagrazia Tateo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2023
Diagnosis and management of hepatic encephalopathy: The French recommendationsDominique Thabut, Charlotte Bouzbib, Lucy Meunier, et al.
The New England Journal of Medicine|June 7, 2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, et al.
Journal of Hepatology|January 27, 2021
Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA scoreEleonora De Martin, Audrey Coilly, Olivier Chazouillères, et al.
BMC Infectious Diseases|January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosisGeorges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Journal of Hepatology|June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLDGrazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.
Lancet (London, England)|February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyFabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Journal of Hepatology|June 6, 2016
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT studyAudrey Coilly, Claire Fougerou-Leurent, Victor de Ledinghen, et al.
Hepatology (Baltimore, Md.)|April 11, 2018
12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver TransplantationPauline Houssel-Debry, Audrey Coilly, Claire Fougerou-Leurent, et al.
Journal of Hepatology|April 11, 2019
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the differenceLina Mouna, Emilie Rossignol, Mariagrazia Tateo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2023
Diagnosis and management of hepatic encephalopathy: The French recommendationsDominique Thabut, Charlotte Bouzbib, Lucy Meunier, et al.
The New England Journal of Medicine|June 7, 2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, et al.
Journal of Hepatology|January 27, 2021
Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA scoreEleonora De Martin, Audrey Coilly, Olivier Chazouillères, et al.
BMC Infectious Diseases|January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosisGeorges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Journal of Hepatology|June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLDGrazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.
Lancet (London, England)|February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyFabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
Pageof 18